Brokerages Anticipate Exantas Capital Corp (XAN) to Announce $0.24 EPS

Share on StockTwits

Shares of Exantas Capital Corp (NYSE:XAN) have been given a consensus broker rating score of 2.00 (Buy) from the three analysts that provide coverage for the stock, Zacks Investment Research reports. One analyst has rated the stock with a hold rating, one has issued a buy rating and one has given a strong buy rating to the company. Exantas Capital’s rating score has declined by 14.3% from three months ago as a result of a number of analysts’ ratings changes.

Brokerages have set a 12 month consensus price target of $12.33 for the company and are forecasting that the company will post $0.24 earnings per share for the current quarter, according to Zacks. Zacks has also given Exantas Capital an industry rank of 206 out of 255 based on the ratings given to its competitors.

A number of equities analysts recently commented on XAN shares. Zacks Investment Research cut Exantas Capital from a “hold” rating to a “sell” rating in a report on Saturday, March 9th. ValuEngine lowered Exantas Capital from a “buy” rating to a “hold” rating in a research report on Friday, March 1st.

A number of hedge funds have recently made changes to their positions in XAN. Quantamental Technologies LLC purchased a new stake in Exantas Capital during the fourth quarter worth $31,000. Legal & General Group Plc lifted its position in shares of Exantas Capital by 28.8% in the fourth quarter. Legal & General Group Plc now owns 6,214 shares of the company’s stock valued at $62,000 after acquiring an additional 1,390 shares in the last quarter. BNP Paribas Arbitrage SA lifted its position in shares of Exantas Capital by 95.1% in the first quarter. BNP Paribas Arbitrage SA now owns 6,967 shares of the company’s stock valued at $74,000 after acquiring an additional 3,396 shares in the last quarter. Metropolitan Life Insurance Co. NY lifted its position in shares of Exantas Capital by 260.8% in the fourth quarter. Metropolitan Life Insurance Co. NY now owns 8,465 shares of the company’s stock valued at $85,000 after acquiring an additional 6,119 shares in the last quarter. Finally, SG Americas Securities LLC purchased a new stake in shares of Exantas Capital in the third quarter valued at $124,000. 66.66% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Exantas Capital stock traded up $0.09 on Wednesday, hitting $11.04. 181,630 shares of the company traded hands, compared to its average volume of 143,143. The stock has a market cap of $347.67 million, a P/E ratio of 15.55 and a beta of 0.80. The company has a debt-to-equity ratio of 2.81, a current ratio of 132.44 and a quick ratio of 132.44. Exantas Capital has a 52 week low of $9.67 and a 52 week high of $12.09.

Exantas Capital (NYSE:XAN) last announced its earnings results on Tuesday, March 5th. The company reported $0.24 EPS for the quarter, topping the Zacks’ consensus estimate of $0.23 by $0.01. The business had revenue of $15.58 million during the quarter, compared to the consensus estimate of $14.70 million. Exantas Capital had a net margin of 49.61% and a return on equity of 2.75%. As a group, equities analysts expect that Exantas Capital will post 1.01 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 26th. Investors of record on Friday, March 29th were issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 7.25%. The ex-dividend date was Thursday, March 28th. This is a positive change from Exantas Capital’s previous quarterly dividend of $0.18. Exantas Capital’s dividend payout ratio is currently 112.68%.

About Exantas Capital

Exantas Capital Corp., a real estate investment trust, primarily focuses on the origination, holding, and management of commercial mortgage loans and commercial real estate-related debt investments in the United States. It invests in commercial real estate-related assets, including first mortgage loans, first priority interests in first mortgage loans, subordinated interests in first mortgage loans, mezzanine debt, preferred equity investments related to commercial real estate (CRE), commercial mortgage-backed securities, and CRE equity investments.

Further Reading: How is the Producer Price Index calculated?

Get a free copy of the Zacks research report on Exantas Capital (XAN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Exantas Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exantas Capital and related companies with MarketBeat.com's FREE daily email newsletter.